Indeed, resveratrol has previously been reported to bind to the integrin αvβ3 receptor in breast cancer cells, thereby activating ERK1/2 and AMPK to induce COX-2 accumulation, and subsequently, p53-dependent apoptosis [29]. The gene discussed is TP53; the disease is breast carcinoma.